PRECISION BIOSCIENCES INC (DTIL)

Latest Insider Confidence Score

2026Q1

46.1
Bearish

Company insider confidence (by quarter)

2019Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Goodman Corey S 10% Owner 467,518 Apr 1, 2019
Adelman Robert J Director 467,518 Apr 1, 2019
Venbio Global Strategic Fund, L.P. Director 467,518 Apr 1, 2019
Venbio Global Strategic Gp, Ltd. 10% Owner 467,518 Apr 1, 2019
Venbio Global Strategic Gp, L.P. 10% Owner 467,518 Apr 1, 2019

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 17, 2026 Feb 19, 2026 Amoroso Michael CEO Sell 30.0 -20,559 -7.79% ✓ $78.9K
Feb 17, 2026 Feb 19, 2026 Kelly John Alexander CFO Sell 35.6 -8,149 -6.08% ✓ $31.3K
Feb 17, 2026 Feb 19, 2026 Scimeca Dario General Counsel and Secretary Sell 31.9 -4,925 -8.02% ✓ $18.9K
Feb 17, 2026 Feb 19, 2026 SMITH J. JEFFERSON Chief Research Officer Sell 40.6 -4,925 -3.65% ✓ $18.9K
Jan 20, 2026 Jan 22, 2026 Amoroso Michael CEO Sell 21.3 -34,799 -15.07% ✓ $145.1K
Jan 20, 2026 Jan 22, 2026 Scimeca Dario General Counsel and Secretary Sell 23.1 -8,854 -16.53% ✓ $35.7K
Jan 20, 2026 Jan 22, 2026 Kelly John Alexander CFO Sell 26.3 -15,213 -12.50% ✓ $61.3K
Jan 20, 2026 Jan 22, 2026 SMITH J. JEFFERSON Chief Research Officer Sell 31.9 -10,200 -7.95% ✓ $41.1K
Dec 16, 2025 Dec 17, 2025 Germano Geno J Director Buy 91.3 +3,000 14.37% ✗ $14.2K
Dec 16, 2025 Dec 17, 2025 Frankel Stanley Director Buy 91.3 +2,700 16.09% ✗ $12.7K
Dec 15, 2025 Dec 17, 2025 Brown Melinda Director Buy 85.0 +1,381 6.29% ✗ $6.9K
Nov 2, 2025 Nov 4, 2025 Kelly John Alexander CFO Sell 50.0 -1,303 -1.66% ✓ $8.5K
Nov 2, 2025 Nov 4, 2025 Scimeca Dario General Counsel and Secretary Sell 46.3 -665 -2.30% ✓ $4.3K
Nov 2, 2025 Nov 4, 2025 Amoroso Michael CEO Sell 45.0 -3,409 -2.87% ✓ $22.1K
Sep 26, 2025 Sep 30, 2025 Frankel Stanley Director Buy 91.3 +2,700 19.18% ✗ $13.4K
Sep 22, 2025 Sep 24, 2025 Brown Melinda Director Buy 85.0 +1,400 6.81% ✗ $6.8K
Jul 3, 2025 Jul 8, 2025 Kelly John Alexander CFO Sell 20.0 -14,827 -16.79% ✓ $63.2K
Jun 25, 2025 Jun 27, 2025 Brown Melinda Director Buy 85.0 +1,682 8.91% ✗ $7K
Jun 25, 2025 Jun 27, 2025 Buehler Kevin Director Buy 91.3 +5,076 22.01% ✗ $21.1K
May 27, 2025 Jun 4, 2025 Germano Geno J Director Neutral 52.5 - 0.00% ✗ -
May 27, 2025 Jun 4, 2025 Pire Shari Lisa Director Neutral 52.5 - 0.00% ✗ -
May 27, 2025 Jun 4, 2025 Frankel Stanley Director Neutral 52.5 - 0.00% ✗ -
May 27, 2025 Jun 4, 2025 Buehler Kevin Director Neutral 52.5 - 0.00% ✗ -
May 27, 2025 Jun 4, 2025 Brown Melinda Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2025 Jun 4, 2025 SMITH J. JEFFERSON Chief Research Officer Neutral 52.5 - 0.00% ✗ -
Jun 2, 2025 Jun 4, 2025 Scimeca Dario General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Jun 2, 2025 Jun 4, 2025 Amoroso Michael CEO Neutral 52.5 - 0.00% ✗ -
Jun 2, 2025 Jun 4, 2025 Kelly John Alexander CFO Neutral 52.5 - 0.00% ✗ -
Mar 26, 2025 Mar 28, 2025 Buehler Kevin Director Buy 91.3 +4,523 51.92% ✗ $21.1K
Mar 26, 2025 Mar 28, 2025 Brown Melinda Director Buy 90.0 +1,839 25.48% ✗ $8.7K
Mar 25, 2025 Mar 27, 2025 Germano Geno J Director Buy 91.3 +3,250 41.63% ✗ $17.2K
Mar 21, 2025 Mar 25, 2025 Amoroso Michael CEO Sell 52.5 -964 -0.87% ✓ $5.4K
Mar 3, 2025 Mar 5, 2025 SMITH J. JEFFERSON Chief Research Officer Sell 55.0 -154 -0.16% ✓ $756.1
Mar 3, 2025 Mar 5, 2025 Kelly John Alexander CFO Neutral 52.5 - 0.00% ✗ -
Mar 3, 2025 Mar 5, 2025 Scimeca Dario General Counsel and Secretary Sell 50.0 -272 -1.08% ✓ $1.3K
Jan 20, 2025 Jan 22, 2025 Scimeca Dario General Counsel and Secretary Sell 13.8 -8,928 -26.83% ✓ $42.8K
Jan 20, 2025 Jan 22, 2025 Kelly John Alexander CFO Neutral 52.5 - 0.00% ✗ -
Jan 20, 2025 Jan 22, 2025 Amoroso Michael CEO Sell 10.0 -36,838 -25.60% ✓ $172K
Jan 20, 2025 Jan 22, 2025 SMITH J. JEFFERSON Chief Research Officer Sell 32.5 -10,287 -9.74% ✓ $49.3K
Dec 30, 2024 Jan 2, 2025 Germano Geno J Director Buy 91.3 +3,605 85.79% ✗ $16.2K
Dec 27, 2024 Dec 31, 2024 Buehler Kevin Director Buy 91.3 +4,320 98.36% ✗ $21.1K
Dec 27, 2024 Dec 31, 2024 Kelly John Alexander CFO Buy 86.3 +2,113 5.55% ✗ $10K
Dec 26, 2024 Dec 30, 2024 Brown Melinda Director Buy 91.3 +3,016 71.78% ✗ $13.7K
Nov 21, 2024 Nov 21, 2024 Kelly John Alexander CFO Buy 86.3 +3,000 8.55% ✗ $20.3K
Nov 2, 2024 Nov 5, 2024 Kelly John Alexander CFO Neutral 52.5 - 0.00% ✗ -
Nov 2, 2024 Nov 5, 2024 Scimeca Dario General Counsel and Secretary Sell 37.5 -588 -6.87% ✓ $4.8K
Nov 2, 2024 Nov 5, 2024 Amoroso Michael CEO Sell 46.3 -3,012 -9.55% ✗ $24.7K
Aug 22, 2024 Aug 23, 2024 SMITH J. JEFFERSON Chief Research Officer Neutral 52.5 - 0.00% ✗ -
Aug 22, 2024 Aug 23, 2024 Kelly John Alexander CFO Neutral 52.5 - 0.00% ✗ -
Aug 22, 2024 Aug 23, 2024 Amoroso Michael CEO Neutral 52.5 - 0.00% ✗ -
Aug 22, 2024 Aug 23, 2024 Scimeca Dario General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 11, 2024 Scimeca Dario General Counsel and Secretary Sell 50.0 -93 -1.36% ✓ $1.1K
Jun 7, 2024 Jun 11, 2024 Kelly John Alexander CFO Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 11, 2024 SMITH J. JEFFERSON Chief Research Officer Sell 52.5 -50 -0.07% ✗ $589.5
Jun 4, 2024 Jun 6, 2024 Brown Melinda Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 6, 2024 Buehler Kevin Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 6, 2024 Frankel Stanley Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 6, 2024 Germano Geno J Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 6, 2024 Pire Shari Lisa Director Neutral 52.5 - 0.00% ✗ -
Jun 4, 2024 Jun 6, 2024 Wadsworth Samuel C. Director Neutral 52.5 - 0.00% ✗ -
May 8, 2024 May 8, 2024 Amoroso Michael CEO Neutral 90.0 +8,334 60.51% ✗ -
May 8, 2024 May 8, 2024 Kelly John Alexander CFO Neutral 90.0 +8,334 36.75% ✗ -
May 8, 2024 May 8, 2024 SMITH J. JEFFERSON Chief Research Officer Neutral 77.5 +833 1.10% ✗ -
May 8, 2024 May 8, 2024 Scimeca Dario General Counsel and Secretary Neutral 90.0 +833 14.67% ✗ -
May 4, 2024 May 7, 2024 Pire Shari Lisa Director Neutral 52.5 - 0.00% ✗ -
May 4, 2024 May 7, 2024 Buehler Kevin Director Neutral 52.5 - 0.00% ✗ -
May 4, 2024 May 7, 2024 Wadsworth Samuel C. Director Neutral 52.5 - 0.00% ✗ -
May 4, 2024 May 7, 2024 Germano Geno J Director Neutral 52.5 - 0.00% ✗ -
May 4, 2024 May 7, 2024 Frankel Stanley Director Neutral 52.5 - 0.00% ✗ -
May 4, 2024 May 7, 2024 Brown Melinda Director Neutral 52.5 - 0.00% ✗ -
Feb 29, 2024 May 3, 2024 Kelly John Alexander CFO Neutral 77.5 +506 2.47% ✗ -
May 1, 2024 May 3, 2024 Scimeca Dario General Counsel and Secretary Sell 42.5 -272 -4.57% ✓ $2.8K
Feb 29, 2024 May 3, 2024 SMITH J. JEFFERSON Chief Research Officer Sell 67.5 +852 0.60% ✗ $1.6K
May 1, 2024 May 3, 2024 List Alan Chief Medical Officer Sell 37.5 -290 -6.07% ✓ $3K
May 1, 2024 May 3, 2024 Amoroso Michael CEO Sell 32.5 -1,526 -9.98% ✓ $15.7K
Apr 26, 2024 Apr 30, 2024 List Alan Chief Medical Officer Sell 37.5 -238 -5.90% ✓ $2.4K
Apr 18, 2024 Apr 22, 2024 SMITH J. JEFFERSON Chief Research Officer Neutral 52.5 - 0.00% ✗ -
Apr 18, 2024 Apr 22, 2024 Amoroso Michael CEO Neutral 52.5 - 0.00% ✗ -
Apr 18, 2024 Apr 22, 2024 Scimeca Dario General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Apr 18, 2024 Apr 22, 2024 Kelly John Alexander CFO Neutral 52.5 - 0.00% ✗ -
Jan 20, 2024 Jan 23, 2024 Kelly John Alexander CFO Neutral 52.5 - 0.00% ✗ -
Jan 20, 2024 Jan 23, 2024 Amoroso Michael CEO Sell 13.8 -137,390 -27.82% ✓ $49.5K
Jan 20, 2024 Jan 23, 2024 Scimeca Dario General Counsel and Secretary Sell 30.0 -21,287 -12.35% ✓ $7.7K
Jan 20, 2024 Jan 23, 2024 List Alan Chief Medical Officer Sell 25.0 -21,526 -18.48% ✓ $7.7K
Jan 20, 2024 Jan 23, 2024 SMITH J. JEFFERSON Chief Research Officer Sell 46.3 -28,000 -1.24% ✗ $10.4K
Nov 2, 2023 Nov 6, 2023 Scimeca Dario General Counsel and Secretary Sell 30.0 -16,023 -12.42% ✓ $6.4K
Nov 2, 2023 Nov 6, 2023 Amoroso Michael CEO Sell 10.0 -125,025 -35.51% ✓ $50K
Nov 2, 2023 Nov 6, 2023 Kelly John Alexander CFO Neutral 52.5 - 0.00% ✗ -
Aug 18, 2023 Oct 27, 2023 Kelly John Alexander CFO Buy 91.3 +90,000 30.68% ✗ $43.2K
Aug 31, 2023 Sep 5, 2023 Scimeca Dario General Counsel and Secretary Neutral 85.0 +5,443 7.95% ✗ -
Aug 31, 2023 Sep 5, 2023 SMITH J. JEFFERSON Chief Research Officer Neutral 60.0 +5,175 0.24% ✗ -
Aug 31, 2023 Sep 5, 2023 Kelly John Alexander CFO Neutral 77.5 +5,951 1.55% ✗ -
Aug 18, 2023 Aug 22, 2023 Kelly John Alexander CFO Neutral 90.0 +90,000 30.68% ✗ -
Jun 7, 2023 Jun 9, 2023 Barton Shane VP & Corporate Controller Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 9, 2023 Kelly John Alexander CFO Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 9, 2023 SMITH J. JEFFERSON Chief Research Officer Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 9, 2023 Scimeca Dario General Counsel and Secretary Sell 23.8 -13,361 -16.33% ✓ $10K
May 4, 2023 May 8, 2023 Frankel Stanley Director Neutral 52.5 - 0.00% ✗ -
May 4, 2023 May 8, 2023 Buehler Kevin Director Neutral 52.5 - 0.00% ✗ -
May 4, 2023 May 8, 2023 Wadsworth Samuel C. Director Neutral 52.5 - 0.00% ✗ -